BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2264373)

  • 41. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices.
    Gottlieb AB; Mease PJ; Mark Jackson J; Eisen D; Amy Xia H; Asare C; Stevens SR
    J Dermatolog Treat; 2006; 17(5):279-87. PubMed ID: 17092858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis.
    Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA
    Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Psoriatic arthritis: case report of acute HLA-B27 positive polyarthritis preceding the onset of typical skin changes].
    Lenert P; Jovanović M; Mitić I; Ivek L; Vasin M; Curić S
    Med Pregl; 1997; 50(9-10):387-90. PubMed ID: 9471536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis.
    Morgan C; Lunt M; Bunn D; Scott DG; Symmons DP
    Rheumatology (Oxford); 2007 Dec; 46(12):1819-23. PubMed ID: 18032539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on psoriatic osteopathy.
    Hein G; Abendroth K; Müller A; Wessel G
    Clin Rheumatol; 1991 Mar; 10(1):13-7. PubMed ID: 2065500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of Enthesopathy with Ultrasonography and Comparison with Skin Findings in Asymptomatic Psoriatic Patients.
    Oğuz ID; Gül Ü; Koparal SS; Deren T; Külcü Çakmak S; Bodur H; Yilmaz Ö
    Dermatology; 2016; 232(3):312-8. PubMed ID: 27028326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Metabolism, vascular tonus and the bone-joint system of psoriasis patients].
    Zaerko VV; Shvyrkova II; Shakhtmeĭster IIa
    Vestn Dermatol Venerol; 1990; (6):33-5. PubMed ID: 2220061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Skin disease effects the bones. Nail involvement suggests psoriatic arthritis].
    Moreano B
    MMW Fortschr Med; 2014 Nov; 156 Spec no 2():1. PubMed ID: 25551989
    [No Abstract]   [Full Text] [Related]  

  • 50. Beyond early diagnosis: occult psoriatic arthritis.
    Palazzi C; Lubrano E; D'Angelo S; Olivieri I
    J Rheumatol; 2010 Aug; 37(8):1556-8. PubMed ID: 20675851
    [No Abstract]   [Full Text] [Related]  

  • 51. Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes.
    Caputo V; Strafella C; Termine A; Dattola A; Mazzilli S; Lanna C; Cosio T; Campione E; Novelli G; Giardina E; Cascella R
    J Cell Mol Med; 2020 Dec; 24(23):13554-13563. PubMed ID: 33128843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance.
    Burden AD; Hilton Boon M; Leman J; Wilson H; Richmond R; Ormerod AD;
    BMJ; 2010 Oct; 341():c5623. PubMed ID: 21036815
    [No Abstract]   [Full Text] [Related]  

  • 53. [The clinical value of the hydroxyproline excretion in 24 hour urine compared to other laboratory diagnostic parameters in ankylopoietic spondylarthritis].
    Behling H; Kahlfuss R; Wessel G; Rössner B
    Z Gesamte Inn Med; 1975 Jan; 30(2):58-62. PubMed ID: 1220346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Leukocyte mobilization and occurrence of rhagocytes in psoriatic arthritis and psoriasis vulgaris in skin chamber testing (author's transl)].
    Muffel H; Kluge K; Ruffert K
    Dermatol Monatsschr; 1978 Oct; 164(10):696-702. PubMed ID: 738489
    [No Abstract]   [Full Text] [Related]  

  • 55. Screening for psoriatic arthritis in people with psoriasis.
    Helliwell PS
    J Rheumatol; 2015 May; 42(5):736-8. PubMed ID: 25934876
    [No Abstract]   [Full Text] [Related]  

  • 56. Urinary hydroxyproline in psoriasis.
    Uitto J; Hannuksela M
    Dermatologica; 1971; 142(2):99-102. PubMed ID: 5575287
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk factors and predictors of psoriatic arthritis in patients with psoriasis.
    Azevedo VF; Buiar PG
    An Bras Dermatol; 2013; 88(2):233-6. PubMed ID: 23739697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disease assessment in psoriatic spectrum: a modular approach for use in routine clinical practice.
    Wajed J; Helliwell P; Korendowych E; Gadsby K; Oliver S; Parrish L; Kirkham B
    Ann Rheum Dis; 2014 Jan; 73(1):318-9. PubMed ID: 23994863
    [No Abstract]   [Full Text] [Related]  

  • 59. Is psoriasis a skin disease or a form of arthritis?
    Duke Med Health News; 2009 Aug; 15(8):8. PubMed ID: 19768838
    [No Abstract]   [Full Text] [Related]  

  • 60. [Psoriasis and oxidative stress].
    Péter I; Jagicza A; Ajtay Z; Kiss I; Németh B
    Orv Hetil; 2016 Nov; 157(45):1781-1785. PubMed ID: 27817235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.